Article Details

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in ...

Retrieved on: 2025-04-01 21:29:56

Tags for this article:

Click the tags to see associated articles and topics

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in .... View article details on hiswai:

Excerpt

... monoclonal antibody, as a therapeutic radiopharmaceutical targeting platform. Olaratumab targets platelet-derived growth factor receptor alpha ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up